Radiotherapy quality assurance in the PROTECT trial - a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer.
Skinnerup Byskov C, Mortensen HR, Biston MC, Broggi S, Bütof R, Canters R, Crehange G, Defraene G, Doyen J, Ehmsen ML, Fabiano S, Fracchiola F, Goudjil F, Haustermans K, Jensen SE, Jensen MF, Lecornu M, Makocki S, Mana AL, Martignano A, Meijers A, Mirandola A, Mitrea DA, Muijs CT, Møller DS, Nordsmark M, Orlandi E, Balermpas P, Populaire P, Scartoni D, Serrand J, Shamshad M, Slim N, Vanoni V, Vela A, Vidal M, Vilches-Freixas G, Weber D, Hoffmann L.
Skinnerup Byskov C, et al. Among authors: fabiano s.
Acta Oncol. 2025 Mar 13;64:406-414. doi: 10.2340/1651-226X.2025.42774.
Acta Oncol. 2025.
PMID: 40079654
Free PMC article.
Clinical Trial.